Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Øresund Pharma ApS
APS
Active
Advertising protection
CVR 39492059
Orient Plads 1, 2150
Nordhavn
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2018 · 8 years old
21 employees
www.oresundpharma.com
Monitor
Share
Denmark
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Øresund Pharma ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
12M
23M
35M
46M
7M
2021
17M
2022
38M
2023
40M
2024
40M
2025
EBITDA
DKK millions
29M
22M
14M
7M
0M
2M
2021
7M
+250%
2022
23M
+229%
2023
20M
-13%
2024
13M
-35%
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Gross profit
7.275
17.238
38.260
39.622
39.702
Staff expenses
-5.576
-10.055
-15.090
-19.757
-26.321
EBITDA
1.699
7.183
23.169
19.865
13.381
Depreciation & amort.
-889
-1.065
-1.228
-2.229
-4.248
EBIT
810
6.118
21.942
17.636
9.133
Net financials
-398
-595
-459
-1
-774
Profit before tax
412
5.523
21.483
17.634
8.358
Tax
131
1.221
4.732
3.927
1.891
Net profit
281
4.302
16.751
13.707
6.467
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
23.913
30.951
42.518
81.089
127.580
Equity
3.390
7.692
24.443
38.151
44.618
Long-term debt
0
0
0
0
0
Short-term debt
20.499
23.258
18.075
42.863
82.784
Total debt
20.499
23.258
18.075
42.863
82.784
Financial ratios
5-year trend
EBITDA margin (of gross profit)
33.7%
This company
2021
2025
Equity ratio
35.0%
This company
38.2%
Market median
+8% vs market
2021
2025
Return on equity
14.5%
This company
18.4%
Market median
+21% vs market
2021
2025
Net profit margin (of gross profit)
16.3%
This company
2021
2025
Asset turnover (of gross profit)
0.31×
This company
2021
2025
Debt / equity
1.86×
This company
0.62×
Market median
-200% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
More on Øresund Pharma ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network